Continuus Pharmaceuticals is a spinout from MIT that has developed an Integrated Continuous Manufacturing (ICM) platform to transform drug production. Founded in 2012, Continuus aims to enhance affordability and accessibility of pharmaceuticals globally. Their ICM technology streamlines manufacturing, reducing drug production time from months/years to just days, enabling faster delivery of high-quality, affordable medications while addressing supply chain issues. Continuus" breakthrough approach eliminates complex steps, optimizes resource utilization, and provides regulatory advantages. Continuus is establishing a state-of-the-art GMP facility for domestic production of critical medicines. By pioneering innovative pharmaceutical technologies, Continuus is redefining the industry"s manufacturing capabilities.
Visit Company Website
